News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...


  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

Recent Postings



Zerenex Amgen (AMGN) Regeneron (REGN) Dynavax (DVAX) GlaxoSmithKline (GSK) AERIE PHARMACEUTICALS Intercept (ICPT) ImmunoGen (IMGN) JOUNCE THERAPEUTICS (JNCE) Roche (ROCHE) HALOZYME (HALO) Sanofi-Aventis (SAN) ARGOS (ARGS) Sarepta (SRPT) INNOVIVA (INVA) Human Longevity (HLI) Roche (RHHBY) Biogen Idec (BIIB) IDERA (IDRA) Biocryst (BCRX) Intrexon (XON) Galena (GALE) Sanofi (SNY) Dendreon (DNDN) Sanofi (SNA) Anacor (ANAC) Ariad (ARIA) Vertex (VRTX) SERES THERAPEUTICS (MCRB) Abbott Laboratories (ABT) Human Genome Sciences (HGSI) Sequenom (SQNM) Tysabri Exelixis (EXEL) Sangamo (SGMO) Endometrial Cancer MODERNA ARCA (ABIO) REGULUS (RGLS) Agenus (AGEN) Ridaforolimus AGOS (ARGS) NANTKWEST (NK) BIOMARIN (BMRN) Pluristem (PSTI) Editas (EDIT) Auspex (ASPX) Vitae Pharmaceuticals (VTAE) Inovio (INO) Theravance (THRX) JUNO (JUNO) Benlysta (belimumab) Adaptimmune (ADAP) Cytokinetics (CYTK) Onyx (ONXX) Prosensa (RNA) Spike Therapeutics (ONCE) Velcade (bortezomib) Alnylam (ALNY) CEMPRA (CEMP) PORTOLA (PTLA) Multiple Myeloma KERYX (KERX) Elan (ELN) Illumina (ILMN) ZALTRAP™ Alder Biopharmaceuticals (ALDR) Xoma (XOMA) Incyte (INCY) RenenxBio (RGNX) Ocular Therapeutix (OCUL) Gilead (GILD) Revlimid (lenolidamide) CompuGen (CGEN) Herceptin Trastuzumab-DM1 Mirati Therapeutics (MRTX) NEKTAR (NKTR)) NOVOCURE (NVCR) ACADIA (ACAD) C4 Therapeutics Aimmune Therapeutics (AIMT) Theravance Bio Pharma (TBPH) Prolor Biotech (PBTH) VANDA (VNDA) OSI (OSIP) Micromet (MITI) ADVENTRIX (ANX) Bristol-Myers Squibb (BMY) Ziofpharm (ZIOP) Global Cell Therapeutics (GBT) galapagos (GLPG) TOKAI (TKAOI) CRISPR Therapeutics (CRSP) Idenix (IDIX) AstraZeneca (AZN) Rapamune Intermune (ITMN) Agenus (AGEN ISIS (ISIS) KITE (KITE) Merck (MRK) Valeant Pharmaceuticals International (VRX) Bellicum (BLCM) PTC Therapeutics (PTCT) SUNESIS PHARMACEUTICALS (SNSS) Jazz Pharmaceuticals (JAZZ) GUARDIAN HEALTH Ionis (IONS) Genentech Anadys (ANDS) Array Pharmaceuticals (ARRY) Advaxis (ADXS) Telaprevir Seattle Genetics (SGEN) ABBVIE (ABBV) SYNTA (SNTA)